Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$37.27M
↑ 120% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
$-188.19M
Historical baseline
PeriodValueYoY Change
TTM$37.27M+149.2%
2024$-75.75M+71.5%
2023$-266.00M-19.7%
2022$-222.26M+32.9%
2021$-331.12M-10.1%
2020$-300.72M-4.2%
2019$-288.54M-23.7%
2018$-233.33M-93.5%
2017$-120.58M-49.1%
2016$-80.86M-